Bimekizumab, a humanised monoclonal antibody, is the first and only dual inhibitor of IL-17A and IL-17F, two pro-inflammatory ...
Abstract: The effectiveness of bearing fault diagnosis techniques is frequently compromised by constraints such as inadequate feature representation and limited data availability, which hinder the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results